This site is intended for Healthcare professionals only.

Alembic Pharma gets USFDA nod for generic hypertension drug

Alembic Pharma gets USFDA nod for generic hypertension drug

New Delhi: Alembic Pharmaceuticals has received US health regulator’s approval to market hypertension drug, candesartan cilexetil tablets, in the American market.

The company’s product is therapeutically equivalent to AstraZeneca Pharmaceuticals’ Atacand tablets which are indicated for treatment of hypertension, Alembic said in a regulatory filing.

As per IMS data, candesartan cilexetil tablets had an estimated market size of USD 27 million in the US market for twelve months ended December 2016.

Alembic now has a total of 57 abbreviated new drug application (ANDA) approvals from the USFDA.

Source: PTI
0 comment(s) on Alembic Pharma gets USFDA nod for generic hypertension drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted